A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
Public ClinicalTrials.gov record NCT03875534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ACHieve: A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.
Study identification
- NCT ID
- NCT03875534
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 0 Years to 8 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2019 (Actual)
- Primary completion
- Jan 12, 2024 (Actual)
- Completion
- Jan 12, 2024 (Actual)
- Last update posted
- Mar 19, 2024
2019 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ascendis Pharma Investigational Site | Little Rock | Arkansas | 72211 | — |
| Ascendis Pharma Investigational Site | Oakland | California | 94609 | — |
| Ascendis Pharma Investigational Site | Aurora | Colorado | 80045 | — |
| Ascendis Pharma Investigational Site | Wilmington | Delaware | 19803 | — |
| Ascendis Pharma Investigational Site | Saint Paul | Minnesota | 55102 | — |
| Ascendis Pharma Investigational Site | Columbia | Missouri | 65212 | — |
| Ascendis Pharma Investigational Site | Buffalo | New York | 14203 | — |
| Ascendis Pharma Investigational Site | Houston | Texas | 77030 | — |
| Ascendis Pharma Investigational Site | Seattle | Washington | 98105 | — |
| Ascendis Pharma Investigational Site | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03875534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2024 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03875534 live on ClinicalTrials.gov.